MicroConstants China has signed a licensing agreement to gain the global rights for the development of AA98 antibody drug candidates from the Institute of Biophysics of the Chinese Academy of Sciences in a unique deal between academia and local industry.

…read more

Source: MicroConstants leverages Chinese Academy of Sciences antibody rights in license deal